1. Home
  2. BLFY vs BIOA Comparison

BLFY vs BIOA Comparison

Compare BLFY & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • BIOA
  • Stock Information
  • Founded
  • BLFY 1939
  • BIOA 2015
  • Country
  • BLFY United States
  • BIOA United States
  • Employees
  • BLFY N/A
  • BIOA N/A
  • Industry
  • BLFY Commercial Banks
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLFY Finance
  • BIOA Health Care
  • Exchange
  • BLFY Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • BLFY 185.3M
  • BIOA 175.7M
  • IPO Year
  • BLFY N/A
  • BIOA 2024
  • Fundamental
  • Price
  • BLFY $8.08
  • BIOA $7.47
  • Analyst Decision
  • BLFY Hold
  • BIOA Hold
  • Analyst Count
  • BLFY 1
  • BIOA 4
  • Target Price
  • BLFY $10.00
  • BIOA $9.00
  • AVG Volume (30 Days)
  • BLFY 42.8K
  • BIOA 651.5K
  • Earning Date
  • BLFY 10-29-2025
  • BIOA 11-06-2025
  • Dividend Yield
  • BLFY N/A
  • BIOA N/A
  • EPS Growth
  • BLFY N/A
  • BIOA N/A
  • EPS
  • BLFY N/A
  • BIOA N/A
  • Revenue
  • BLFY $44,731,000.00
  • BIOA $3,863,000.00
  • Revenue This Year
  • BLFY $19.02
  • BIOA N/A
  • Revenue Next Year
  • BLFY $17.51
  • BIOA N/A
  • P/E Ratio
  • BLFY N/A
  • BIOA N/A
  • Revenue Growth
  • BLFY 11.52
  • BIOA N/A
  • 52 Week Low
  • BLFY $7.93
  • BIOA $2.88
  • 52 Week High
  • BLFY $11.38
  • BIOA $23.85
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 32.06
  • BIOA 65.58
  • Support Level
  • BLFY $8.51
  • BIOA $7.09
  • Resistance Level
  • BLFY $8.44
  • BIOA $8.15
  • Average True Range (ATR)
  • BLFY 0.22
  • BIOA 0.47
  • MACD
  • BLFY -0.04
  • BIOA 0.08
  • Stochastic Oscillator
  • BLFY 17.02
  • BIOA 68.17

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: